Close
  Indian J Med Microbiol
 

Figure 1: Antiproliferative effects of annonacin on endometrial cancer cells (a) molecular structure of annonacin. (b) ECC-1, HEC-1A, EC6-ept, and EC14-ept were treated with 0.2–100 μg/ml of annonacin in an increasing dose for 72 h. The cell viability was assessed by methyl thiazolyl tetrazolium assay with triplicate samples. The cell viability with annonacin treatment was normalized to control media containing 10% FBS. *P < 0.05, **P < 0.01, ***P < 0.001. ECC: Endometrial cancer cell, EC: Endometrial cancer, FBS: Fetal bovine serum

Figure 1: Antiproliferative effects of annonacin on endometrial cancer cells (a) molecular structure of annonacin. (b) ECC-1, HEC-1A, EC6-ept, and EC14-ept were treated with 0.2–100 μg/ml of annonacin in an increasing dose for 72 h. The cell viability was assessed by methyl thiazolyl tetrazolium assay with triplicate samples. The cell viability with annonacin treatment was normalized to control media containing 10% FBS. *<i>P</i> < 0.05, **<i>P</i> < 0.01, ***<i>P</i> < 0.001. ECC: Endometrial cancer cell, EC: Endometrial cancer, FBS: Fetal bovine serum